Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) has issued a proxy form for its 2026 Second H Share Class Meeting, to be held on 9 June 2026 at the company’s headquarters in Binjiang District, Hangzhou.

The sole agenda item is a special resolution authorising an on-market repurchase of A shares through centralized price bidding. The proposed mandate covers eight specific aspects:

1. Purpose and intended use of the repurchased shares 2. Confirmation that statutory conditions for the buy-back are met 3. Repurchase methodology 4. Maximum number and proportion of shares to be bought back 5. Aggregate funding limit and funding source 6. Pricing range and pricing principles 7. Repurchase period 8. Board mandate to execute and handle all related matters

Shareholders of H shares may appoint proxies; completed forms must reach the company’s H-share registrar, Tricor Investor Services Limited, no later than 24 hours before the meeting.

The H-Share Class Meeting will convene after the conclusion or adjournment of TIGERMED’s 2026 Second Extraordinary General Meeting and the 2026 Second A Share Class Meeting on the same day. Shareholders attending in person or by proxy are required to present valid identification.